Table 1.

Percentage of alveolar macrophages and neutrophils in bronchoalveolar lavage fluid

Days after LPS	Gefitinib	LPS	SP‐A	Macrophages (%)	Neutrophils (%)
0	–	–	–	93.3 ± 0.3	2.1 ± 0.3
0	+	–	–	89.0 ± 1.5	6.9 ± 1.1
3	–	+	–	34.1 ± 5.5	61.0 ± 6.3
3	+	+	–	21.6 ± 2.4	72.5 ± 3.3
3	+	+	+	43.0 ± 1.6	40.7 ± 1.8**
6	–	+	–	77.3 ± 2.8	6.0 ± 0.3
6	+	+	–	81.1 ± 0.6	13.5 ± 1.1
6	+	+	+	84.6 ± 3.6	1.3 ± 0.5*

^* P < 0.05 (compared with gefitinib+/LPS + mice);

^** P < 0.01 (compared with gefitinib+/LPS + mice). BAL, bronchoalveolar lavage; LPS, lipopolysaccharide; SP, surfactant protein.